AbbVie
ABBV
#35
Rank
$242.69 B
Marketcap
$137.56
Share price
-0.76%
Change (1 day)
-8.29%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2022 : $121.51 B

According to AbbVie's latest financial reports the company's total liabilities are $121.51 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-12-31$121.51 B-7.3%
2021-12-31$131.09 B-4.64%
2020-12-31$137.46 B41.3%
2019-12-31$97.28 B43.5%
2018-12-31$67.79 B3.21%
2017-12-31$65.68 B6.88%
2016-12-31$61.46 B25.17%
2015-12-31$49.10 B90.29%
2014-12-31$25.80 B4.45%
2013-12-31$24.70 B4.49%
2012-12-31$23.64 B218.09%
2011-12-31$7.43 B36.85%
2010-12-31$5.43 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$101.28 B-16.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.86 B-65.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$83.37 B-31.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.81 B-91.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.93 B-66.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$62.39 B-48.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$60.87 B-49.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
$58.57 B-51.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.67 B-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA